Galderma Shatters Records with $2.4B Sales Fueled by Innovative Breakthroughs
Swiss dermatology frontrunner, Galderma, has reported a record-breaking net sales of US$2.448 billion in the first half of 2025. This represents a significant 12.2% year-on-year growth at constant currency. Following an exceptional performance across both therapeutic and aesthetic product categories, the company has revised its full-year guidance upwards.
The impressive growth trajectory has been primarily fueled by the robust uptake of Galderma’s latest therapeutic and aesthetic innovations. This clearly indicates an escalating consumer demand for advanced dermatological treatments. The company’s success is a testament to the wider trend of increasing preference for professional-grade skincare and aesthetic procedures.
This milestone firmly cements Galderma’s position as a global leader in dermatology. Their innovative product portfolio has resonated powerfully with healthcare providers and patients alike, who are in search of effective skin health solutions.
Source: Global Cosmetics News